Vasomotor Symptoms Completed Phase 1 Trials for Elismetrep (DB15287)

IndicationStatusPhase
DBCOND0035305 (Vasomotor Symptoms)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02803268A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor SymptomsOther